SCHEMBL4796147

SCHEMBL4796147

COc1cc(F)ccc1NC(C)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
HSD17B1 P14061 1/20 0.56
HSD17B2 P37059 1/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 3/20 0.54
HTT P42858 1/20 0.54
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
NR3C1 P04150 1/20 0.51
PGR P06401 1/20 0.51
NR3C2 P08235 1/20 0.51
AR P10275 1/20 0.51
EPHX1 P07099 1/20 0.50
HTR3E A5X5Y0 1/20 0.49
HTR3B O95264 1/20 0.49
HTR3A P46098 1/20 0.49
HTR3D Q70Z44 1/20 0.49
HTR3C Q8WXA8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29760424 1.00 ALDH1A1 (0.59) ALDH1A1HSD17B1HSD17B2MEN1KMT2A
SCHEMBL31078153 0.86 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL10747417 0.85 MAPT (0.56) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL24997149 0.83 RORC (0.51) ALDH1A1HSD17B1HSD17B2MAPTPKM
SCHEMBL9400208 0.82 HSD17B1 (0.77) ALDH1A1HSD17B1HSD17B2MEN1KMT2A
SCHEMBL17681670 0.82 PYGL (0.48) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL24535027 0.82 LMNA (0.48) ALDH1A1KMT2AHTTCYP1A2CYP3A4
SCHEMBL29660685 0.82 MAPT (0.50) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL23169455 0.81 HTT (0.53) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL9971092 0.81 TSHR (0.53) ALDH1A1MEN1KMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132477-A1 Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease PFIZER INC. (US) 2024-04-25 US disclosed
WO-2022130171-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF ITK FOR THE TREATMENT OF SKIN DISEASE PFIZER INC. (US) 2022-06-23 WO disclosed
CN-113416139-B 4-fluorine substituted aryl amine compound and synthetic method thereof 江苏笃行致远新材料科技有限公司 2022-06-03 CN disclosed
CN-113416139-A 4-fluorine substituted aryl amine compound and synthetic method thereof 江苏笃行致远新材料科技有限公司 2021-09-21 CN disclosed
WO-2018207120-A1 A PROCESS FOR THE PREPARATION OF 4-FLUORO-2-METHOXY-5-NITROANILINE AUROBINDO PHARMA LIMITED (IN) 2018-11-15 WO disclosed
US-7381728-B2 Piperazine derivatives useful for the treatment of gastrointestinal disorders GLAXO GROUP LIMITED (GB) 2008-06-03 US disclosed
US-20070259877-A1 Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders GLAXO GROUP LIMITED 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132477-A1 Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease ITK, BLK, BCKDK ALDH1A1 412/4885HSD17B1 806/4885HSD17B2 1260/4885
US-20070259877-A1 Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders GHSR, GHRHR, GIPR ALDH1A1 2084/4885HSD17B1 614/4885HSD17B2 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.